NCT06974994 Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
| NCT ID | NCT06974994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Turku University Hospital |
| Condition | Healthy Newborn Infants |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2024-05-08 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2024-05-08 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and respiratory tract infections. A total of 125 mother-child pairs will be recruited in this randomized, double-blind, placebo-controlled study. Infants are randomized to receive either a synbiotic supplement or a placebo for 2 months, after which their growth and morbidity will be monitored at the research clinic for 2 years.
Eligibility Criteria
Inclusion Criteria: Pregnant women (n=125) and their newborn children who receive antibiotic treatment at delivery. Exclusion Criteria: * Chorioamnionitis * Pre-eclampsia and hepatogestosis * Suspected malformation or serious condition of the foetus and neonates * Serious infection or other conditions not permitting breast milk feeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06974994 clinical trial?
This trial is open to participants of all sexes, aged 2 Hours or older, studying Healthy Newborn Infants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06974994 currently recruiting?
Yes, NCT06974994 is actively recruiting participants. Contact the research team at paula.tahtinen@utu.fi for enrollment information.
Where is the NCT06974994 trial being conducted?
This trial is being conducted at Turku, Finland.
Who is sponsoring the NCT06974994 clinical trial?
NCT06974994 is sponsored by Turku University Hospital. The trial plans to enroll 125 participants.